Complete list of 61 Drug Manufacturers - General industry stocks with AI-powered MoonshotScore analysis, real-time price data, and institutional-grade market insights. Part of the Healthcare sector.
The Drug Manufacturers - General industry, part of the Healthcare sector, comprises 61 publicly traded companies with a combined market capitalization of $5.9T. This includes 11 mega-cap companies (over $200B), reflecting the industry's significant weight in global markets.
Today's market sentiment for Drug Manufacturers - General stocks is Bearish, with 22 stocks advancing and 30 declining. The average price movement across the industry is -3.98%.
The average AI MoonshotScore across Drug Manufacturers - General stocks is 53/100, indicating above-average growth potential based on our proprietary analysis combining fundamentals, technicals, and sentiment.
How Drug Manufacturers - General companies are distributed across market capitalization tiers.
There are currently 61 publicly traded companies classified under the Drug Manufacturers - General industry within the Healthcare sector.
Based on our AI MoonshotScore analysis, the top-rated Drug Manufacturers - General stocks are CRXTQ, ORINY, MRK. Always conduct your own research before investing.
The largest Drug Manufacturers - General companies by market capitalization are BMYMP ($814.59B), JNJ ($621.38B), ABBV ($451.72B).
The current average MoonshotScore for the Drug Manufacturers - General industry is 53/100.
Drug Manufacturers - General stocks are tracked against broader market benchmarks. You can compare sector and industry performance on our Market Sectors dashboard.
Stock Expert AI evaluates every publicly traded U.S. stock using the MoonshotScore, a proprietary 0–100 composite rating. The score synthesizes nine quantitative dimensions: revenue growth trajectory, profitability and margins, analyst consensus estimates, insider transaction patterns, institutional ownership shifts, short interest dynamics, technical momentum signals, earnings surprise history, and valuation multiples relative to peers.
Price data is sourced from Financial Modeling Prep (FMP) with Yahoo Finance as a fallback. Fundamental data comes from SEC filings, FMP, and Alpha Vantage. Sentiment signals are derived from aggregated analyst ratings and news flow. All metrics refresh during market hours; after-hours data reflects the most recent closing values.
Sector and industry classifications follow the Global Industry Classification Standard (GICS), the same taxonomy used by S&P and MSCI. Companies are assigned to one of 11 sectors and further classified into 50+ industries based on their primary revenue source.
Data is provided for informational purposes only and should not be considered investment advice. Stock prices, market capitalizations, and MoonshotScores are updated throughout the trading day. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
| Stock | Price | Change | Volume | Market Cap | MoonshotScore | Sector |
|---|---|---|---|---|---|---|
|
CRXTQ
Clarus Therapeutics Holdings, Inc.
|
$0.00 | +0.00% | 38.3K | $72,829 | 68 | Healthcare |
|
ORINY
Orion Oyj
|
$38.86 | +0.00% | 5 | $21.87B | 64 | Healthcare |
|
MRK
Merck & Co., Inc.
|
$126.78 | -2.15% | 8.44M | $313.12B | 64 | Healthcare |
|
ORINF
Orion Oyj
|
$82.75 | +0.00% | 100 | $11.66B | 63 | Healthcare |
|
AZN
AstraZeneca PLC
|
$190.16 | -2.56% | 1.87M | $294.91B | 61 | Healthcare |
|
GSK
GSK plc
|
$53.09 | -1.06% | 4M | 107B | 61 | Healthcare |
|
RHHBY
Roche Holding AG
|
$51.62 | -2.68% | 67.6K | $332.48B | 60.5 | Healthcare |
|
AZNCF
AstraZeneca PLC
|
$189.90 | -1.35% | 1.43M | $294.40B | 60 | Healthcare |
|
AMGN
Amgen Inc.
|
$365.01 | -2.44% | 989.4K | $197.00B | 59 | Healthcare |
|
BIIB
Biogen Inc.
|
$212.58 | -1.64% | 475.4K | $31.39B | 59 | Healthcare |
|
OPHLF
Ono Pharmaceutical Co., Ltd.
|
$14.90 | +2.41% | 701 | $7.00B | 59 | Healthcare |
|
SNY
Sanofi
|
$42.61 | -1.27% | 4.86M | $102.45B | 58 | Healthcare |
|
OTSKY
Otsuka Holdings Co., Ltd.
|
$36.05 | -0.21% | 1.4K | $38.01B | 58 | Healthcare |
|
GLAXF
GSK plc
|
$25.30 | -1.82% | 2.6K | $101.34B | 58 | Healthcare |
|
ALPMF
Astellas Pharma Inc.
|
$14.60 | +3.18% | 1.1K | $26.16B | 58 | Healthcare |
|
OTSKF
Otsuka Holdings Co., Ltd.
|
$64.00 | -3.03% | 400 | $33.67B | 58 | Healthcare |
|
PFE
Pfizer Inc.
|
$23.73 | -2.43% | 50.77M | $135.25B | 58 | Healthcare |
|
CELG-RI
Bristol-Myers Squibb Company Ce
|
$0.10 | +12.36% | 12.1K | $204.21M | 57 | Healthcare |
|
NVS
Novartis AG
|
$155.20 | -2.94% | 1.41M | $296.14B | 57 | Healthcare |
|
KYKOF
Kyowa Kirin Co., Ltd.
|
$14.20 | -1.56% | 17 | $7.43B | 57 | Healthcare |
|
CRXT
Clarus Therapeutics Holdings, Inc.
|
$0.05 | -31.16% | 2.74M | 0 | 56 | Healthcare |
|
GILD
Gilead Sciences, Inc.
|
$129.03 | -1.70% | 4.98M | $160.20B | 55 | Healthcare |
|
CHGCF
Chugai Pharmaceutical Co., Ltd.
|
$46.51 | +0.93% | 10.8K | $76.54B | 55 | Healthcare |
|
CHGCY
Chugai Pharmaceutical Co., Ltd.
|
$23.26 | -0.47% | 16.3K | $76.56B | 55 | Healthcare |
|
BMY
Bristol-Myers Squibb Company
|
$56.73 | -2.40% | 4.10M | $115.86B | 55 | Healthcare |
|
ALPMY
Astellas Pharma Inc.
|
$13.63 | +2.48% | 19.3K | $24.42B | 55 | Healthcare |
|
NVSEF
Novartis AG
|
$156.65 | +2.13% | 100 | $298.90B | 55 | Healthcare |
|
VRBCF
Virbac S.A.
|
$431.80 | +5.83% | 1 | $3.62B | 54 | Healthcare |
|
OPHLY
Ono Pharmaceutical Co., Ltd.
|
$4.99 | +0.10% | 1.3K | $7.03B | 54 | Healthcare |
|
HZNP
Horizon Therapeutics Public Limited Company
|
$116.30 | +0.00% | 24M | 27B | 54 | Healthcare |
|
RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A.
|
$58.00 | +0.00% | 100 | $11.80B | 54 | Healthcare |
|
RHHBF
Roche Holding AG
|
$415.64 | -4.01% | 69 | $330.85B | 54 | Healthcare |
|
RHHVF
Roche Holding AG
|
$411.25 | -2.70% | 338 | $327.35B | 54 | Healthcare |
|
JNJ
Johnson & Johnson
|
$258.13 | -1.87% | 3.53M | $621.38B | 53 | Healthcare |
|
BDSIW
BioDelivery Sciences Intl, Inc. Wrrt
|
$0.04 | -25.00% | 552.1K | 0 | 52 | Healthcare |
|
ABBV
AbbVie Inc.
|
$255.67 | -2.07% | 3.76M | $451.72B | 52 | Healthcare |
|
CTOR
Citius Oncology, Inc.
|
$0.71 | +4.20% | 220.6K | $65.92M | 52 | Healthcare |
|
GIFLF
Grifols, S.A.
|
$10.45 | +0.00% | 5.8K | $7.11B | 52 | Healthcare |
|
BAYRY
Bayer AG
|
$14.56 | -4.11% | 40.8K | $57.24B | 51 | Healthcare |
|
CHJTF
CSPC Pharmaceutical Group Limited
|
$0.98 | +0.00% | 0 | $11.18B | 50 | Healthcare |
|
HAWPY
Haw Par Corporation Limited
|
$54.44 | +1.76% | 7 | $3.01B | 50 | Healthcare |
|
BMYMP
Bristol-Myers Squibb Company PFD CONV 2
|
$400.00 | -57.46% | 13 | $814.59B | 50 | Healthcare |
|
OGN
Organon & Co.
|
$13.52 | -0.26% | 1.23M | $3.55B | 50 | Healthcare |
|
HAWPF
Haw Par Corporation Limited
|
$12.00 | +0.00% | 200 | $2.66B | 49 | Healthcare |
|
LYPHF
Luye Pharma Group Ltd.
|
$0.20 | +0.00% | 500 | $815.28M | 49 | Healthcare |
|
JCRRF
JCR Pharmaceuticals Co., Ltd.
|
$3.31 | +5.25% | 476 | $403.80M | 48 | Healthcare |
|
DPHAY
Dechra Pharmaceuticals PLC
|
$98.00 | +1.98% | 100 | $5.58B | 48 | Healthcare |
|
PSYGF
Psyence Group Inc.
|
$0.14 | +9.76% | 100 | $2.18M | 48 | Healthcare |
|
CSPCY
CSPC Pharmaceutical Group Limited
|
$4.19 | +9.11% | 205 | $12.07B | 48 | Healthcare |
|
SNYNF
Sanofi
|
$85.25 | +0.64% | 4.5K | $102.48B | 48 | Healthcare |
|
GIKLY
Grifols, S.A.
|
$4.77 | -6.47% | 24 | $12.54B | 48 | Healthcare |
|
PTKFF
PT Kalbe Farma Tbk.
|
$0.04 | +11.41% | 10.0K | $2.03B | 47 | Healthcare |
|
SNPHF
Santen Pharmaceutical Co., Ltd.
|
$10.99 | -15.79% | 2.0K | $3.54B | 47 | Healthcare |
|
PTKFY
PT Kalbe Farma Tbk.
|
$8.69 | +4.70% | 6.5K | $9.84M | 47 | Healthcare |
|
MIRA
MIRA Pharmaceuticals, Inc.
|
$0.95 | +0.49% | 62.9K | $39.90M | 46 | Healthcare |
|
GRFS
Grifols, S.A. is a global healthcare company focused on plasma-derived medicines and other innovative solutions. The company
|
$7.21 | +0.77% | 1.08M | $6.10B | 45 | Healthcare |
|
TCRG
The Cannaisseur Group, Inc.
|
$0.00 | -85.00% | 350 | $83,055 | 44 | Healthcare |
|
SNPHY
Santen Pharmaceutical Co., Ltd.
|
$13.90 | +3.08% | 523 | $4.47B | 44 | Healthcare |
|
MAYNF
Mayne Pharma Group Limited
|
$1.65 | +0.00% | 5.0K | $134.06M | 43 | Healthcare |
|
SRXH
SRx Health Solutions Inc.
|
$2.01 | -63.07% | 8.84M | $19.77M | 40 | Healthcare |
|
SCLXW
Scilex Holding Company
|
$0.19 | +5.56% | 8.3K | $70.00M | 0 | Healthcare |
Last updated: 2026-07-05